These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1889485)

  • 21. [Pathological analysis of myelodysplastic syndrome with myelofibrosis].
    Matsunaga T; Kato J
    Rinsho Ketsueki; 2002 Apr; 43(4):252-7. PubMed ID: 12043202
    [No Abstract]   [Full Text] [Related]  

  • 22. Successful treatment with intermediate dose cytosine arabinoside for myelodysplastic syndrome with acute myelofibrosis.
    Takabayashi M; Sakai R; Kanamori H; Ishigatsubo Y
    Leuk Lymphoma; 2003 May; 44(5):891-2. PubMed ID: 12802934
    [No Abstract]   [Full Text] [Related]  

  • 23. The lack of association between JAK2 V617F mutation and myelodysplastic syndrome with or without myelofibrosis.
    Yip SF; So CC; Chan AY; Liu HY; Wan TsK; Chan LC
    Leukemia; 2006 Jun; 20(6):1165. PubMed ID: 16572200
    [No Abstract]   [Full Text] [Related]  

  • 24. Osteolytic lesions in idiopathic myelofibrosis.
    Gruber A; Osby E
    Med Oncol Tumor Pharmacother; 1987; 4(2):107-9. PubMed ID: 3669778
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myelodysplastic syndrome associated with myelofibrosis, a report of 3 cases.
    Kamei S; Shinohara K; Oeda E
    Intern Med; 1993 Aug; 32(8):668-71. PubMed ID: 8312669
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myelodysplastic syndrome with myelofibrosis: myelodysplastic syndrome as a major primary disorder for acute myelofibrosis.
    Takahashi M; Koike T; Nagayama R; Fujiwara M; Koyama S; Ohnishi M; Nakamori Y; Soga N; Aoki S; Tatewaki W
    Clin Lab Haematol; 1991; 13(1):17-23. PubMed ID: 2060260
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Morphological analysis of the megakaryocytes in myelodysplastic syndrome].
    Mori H; Niikura H; Terada H; Fujita K
    Rinsho Byori; 1990 Dec; 38(12):1347-52. PubMed ID: 2082033
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Acute myelofibrosis and acute megakaryoblastic/megakaryocytic leukemia. A study on clinicopathologic correlations in a patient and reports of the literature].
    Hirano K; Takenaka T; Nakamine H; Oshiro I; Maeda J; Kishi T; Murakami S; Yokoya Y; Nishioka S; Yataka I
    Rinsho Ketsueki; 1984 Aug; 25(8):1290-8. PubMed ID: 6542604
    [No Abstract]   [Full Text] [Related]  

  • 29. Severe case of peripheral leukocytosis initially diagnosed as myelodysplastic syndrome/myeloproliferative neoplasm, unclassifiable, but possibly prefibrotic primary myelofibrosis.
    Ota S; Hiramatsu Y; Kondo E; Kasahara A; Takada S; Umena S; Noguchi T; Tanimoto M; Matsumura T
    Acta Med Okayama; 2014 Dec; 68(6):363-8. PubMed ID: 25519030
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transforming growth factor β- and interleukin 13-producing mast cells are associated with fibrosis in bone marrow.
    Nakayama S; Yokote T; Hiraoka N; Akioka T; Nishiwaki U; Miyoshi T; Iwaki K; Fumimoto A; Masuda Y; Hatooka J; Fujimoto M; Nishimura Y; Tsuji M
    Hum Pathol; 2017 Apr; 62():180-186. PubMed ID: 28159675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bone marrow immunohistochemical studies of angiogenic cytokines and their receptors in myelofibrosis with myeloid metaplasia.
    Chou JM; Li CY; Tefferi A
    Leuk Res; 2003 Jun; 27(6):499-504. PubMed ID: 12648509
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extramedullary megakaryoblastic tumors following an indolent phase of myelofibrosis.
    Chubachi A; Wakui H; Miura I; Saitoh M; Nishinari T; Nishimura S; Miura AB
    Leuk Lymphoma; 1995 Apr; 17(3-4):351-4. PubMed ID: 8580808
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Megakaryocytic dysfunction in myelodysplastic syndromes and idiopathic thrombocytopenic purpura is in part due to different forms of cell death.
    Houwerzijl EJ; Blom NR; van der Want JJ; Vellenga E; de Wolf JT
    Leukemia; 2006 Nov; 20(11):1937-42. PubMed ID: 16990774
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thrombocytopenia in myelodysplastic syndromes and myelofibrosis.
    Boruchov AM
    Semin Hematol; 2009 Jan; 46(1 Suppl 2):S37-43. PubMed ID: 19245933
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of biscoclaurine alkaloids, prednisolone and ascorbic acid on myelodysplastic syndrome with pancytopenia: a case report.
    Saito N; Miyamoto M; Gotoh U; Yoshitomi S
    Eur J Haematol; 2000 Jan; 64(1):61-5. PubMed ID: 10680708
    [No Abstract]   [Full Text] [Related]  

  • 36. Myelodysplastic features in visceral leishmaniasis.
    Yarali N; Fişgin T; Duru F; Kara A
    Am J Hematol; 2002 Nov; 71(3):191-5. PubMed ID: 12410574
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary autoimmune myelofibrosis as etiology of pancytopenia mimicking myelodysplastic syndrome.
    Tang VK; Huh YO; Tayar JH; Rojas Hernandez CM
    Leuk Lymphoma; 2016; 57(3):731-4. PubMed ID: 26422082
    [No Abstract]   [Full Text] [Related]  

  • 38. [Myelosclerosis in myelodysplastic syndromes (MDS). Retrospective analysis of 232 patients with MDS].
    Maschek H; Kaloutsi V; Werner M; Bandecar K; Buhr T; Georgii A
    Verh Dtsch Ges Pathol; 1990; 74():144-8. PubMed ID: 1708573
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myeloid metaplasia and osteolytic lesions.
    Leimert JT; Armitage JO; Dick FR
    Am J Clin Pathol; 1978 Oct; 70(4):706-8. PubMed ID: 707437
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [An immunohistochemical study on megakaryocytes in patients with myelodysplastic syndromes].
    Liu SQ; Liu XF; Song SJ
    Zhonghua Bing Li Xue Za Zhi; 1994 Oct; 23(5):288-90. PubMed ID: 7874762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.